JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 9.58% |
| 3 | Consumer Discretionary | 9.07% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SA
5026
Seabridge Gold
SA
$3.62B
| $244K | ﹤0.01% |
16,136
+15,930
| +7,733% | +$186K |
|
5027
Anavex Life Sciences
AVXL
$298M
| $244K | ﹤0.01% |
47,909
-16,527
| -26% | -$93K |
|
5028
AST SpaceMobile
ASTS
$21.3B
| $244K | ﹤0.01% |
84,076
+4,141
| +5% | +$13.9K |
|
5029
PUT
iShares Gold Trust
IAU
$64.9B
| $244K | ﹤0.01% |
+5,800
| New | +$227K |
|
5030
FT Vest International Equity Moderate Buffer ETF March
YMAR
$164M
| $244K | ﹤0.01% |
+10,512
| New | +$235K |
|
5031
Tilly's
TLYS
$122M
| $243K | ﹤0.01% |
35,808
+19,856
| +124% | +$145K |
|
5032
Absci
ABSI
$1.58B
| $243K | ﹤0.01% |
42,789
+42,786
| +1,426,200% | +$193K |
|
|
ITOS
5033
DELISTED
iTeos Therapeutics
ITOS
| $242K | ﹤0.01% |
17,758
-5,494
| -24% | -$59.9K |
|
5034
PUT
Phinia Inc
PHIN
$2.73B
| $242K | ﹤0.01% |
+6,300
| New | +$205K |
|
5035
Mineralys Therapeutics
MLYS
$2.27B
| $242K | ﹤0.01% |
18,738
-4,825
| -20% | -$59.6K |
|
5036
PUT
Madrigal Pharmaceuticals
MDGL
$11.7B
| $240K | ﹤0.01% |
+900
| New | +$212K |
|
|
DFSU
5037
Dimensional US Sustainability Core 1 ETF
DFSU
$2.37B
| $239K | ﹤0.01% |
6,948
+6,699
| +2,690% | +$218K |
|
5038
Gossamer Bio
GOSS
$75.4M
| $238K | ﹤0.01% |
+201,898
| New | +$222K |
|
5039
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$110M
| $238K | ﹤0.01% |
9,954
| – | – |
|
5040
LiveWire
LVWR
$246M
| $238K | ﹤0.01% |
32,910
+11,823
| +56% | +$113K |
|
5041
CareDx
CDNA
$2.34B
| $238K | ﹤0.01% |
22,467
-14,265
| -39% | -$143K |
|
5042
CALL
ResMed
RMD
$32.4B
| $238K | ﹤0.01% |
1,200
-3,200
| -73% | -$586K |
|
|
5043
PUT
ResMed
RMD
$32.4B
| $238K | ﹤0.01% |
+1,200
| New | +$220K |
|
5044
Overlay Shares Foreign Equity ETF
OVF
$54.9M
| $238K | ﹤0.01% |
9,567
-12,735
| -57% | -$301K |
|
5045
Eve Holding
EVEX
$951M
| $237K | ﹤0.01% |
43,939
+3,317
| +8% | +$20.3K |
|
|
MNTX
5046
DELISTED
Manitex International, Inc.
MNTX
| $237K | ﹤0.01% |
34,499
+6,583
| +24% | +$48K |
|
5047
ThredUp
TDUP
$403M
| $237K | ﹤0.01% |
118,291
-11,231
| -9% | -$22.9K |
|
5048
Twin Disc
TWIN
$354M
| $236K | ﹤0.01% |
14,306
+4,496
| +46% | +$70.5K |
|
|
GLDD
5049
DELISTED
Great Lakes Dredge & Dock
GLDD
| $236K | ﹤0.01% |
26,997
-17,235
| -39% | -$142K |
|
|
GTHX
5050
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $236K | ﹤0.01% |
54,634
+54,384
| +21,754% | +$190K |
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $43.6B of net new capital in Q1 2024, opening 625 new positions and adding to 3,258 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 766 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.